Human Gene HECW1 (uc003tid.1)
  Description: Homo sapiens HECT, C2 and WW domain containing E3 ubiquitin protein ligase 1 (HECW1), mRNA.
Transcript (Including UTRs)
   Position: hg19 chr7:43,152,198-43,602,938 Size: 450,741 Total Exon Count: 30 Strand: +
Coding Region
   Position: hg19 chr7:43,283,505-43,601,525 Size: 318,021 Coding Exon Count: 28 

Page IndexSequence and LinksUniProtKB CommentsPrimersGenetic AssociationsCTD
Gene AllelesRNA-Seq ExpressionMicroarray ExpressionRNA StructureProtein StructureOther Species
GO AnnotationsmRNA DescriptionsPathwaysOther NamesModel InformationMethods
Data last updated at UCSC: 2013-06-14

-  Sequence and Links to Tools and Databases
 
Genomic Sequence (chr7:43,152,198-43,602,938)mRNA (may differ from genome)Protein (1606 aa)
Gene SorterGenome BrowserOther Species FASTAVisiGeneGene interactionsTable Schema
AlphaFoldBioGPSEnsemblEntrez GeneExonPrimerGeneCards
GeneNetworkH-INVHGNCHPRDLynxMGI
neXtProtOMIMPubMedReactomeTreefamUniProtKB
WikipediaBioGrid CRISPR DB

-  Comments and Description Text from UniProtKB
  ID: HECW1_HUMAN
DESCRIPTION: RecName: Full=E3 ubiquitin-protein ligase HECW1; EC=6.3.2.-; AltName: Full=HECT, C2 and WW domain-containing protein 1; AltName: Full=NEDD4-like E3 ubiquitin-protein ligase 1; Short=hNEDL1;
FUNCTION: E3 ubiquitin-protein ligase that mediates ubiquitination and subsequent degradation of DVL1. Also targets the mutant SOD1 protein involved in familial amyotrophic lateral sclerosis (FALS). Forms cytotoxic aggregates with DVL1, SSR3 and mutant SOD1 that lead to motor neuron death in FALS.
PATHWAY: Protein modification; protein ubiquitination.
SUBUNIT: Interacts with DVL1 and SSR3. Also interacts with mutant SOD1.
SUBCELLULAR LOCATION: Cytoplasm.
TISSUE SPECIFICITY: Predominantly expressed in neurons of adult and fetal brain. Weakly expressed in the kidney.
SIMILARITY: Contains 1 C2 domain.
SIMILARITY: Contains 1 HECT (E6AP-type E3 ubiquitin-protein ligase) domain.
SIMILARITY: Contains 2 WW domains.
SEQUENCE CAUTION: Sequence=BAA20780.2; Type=Erroneous initiation;

-  Primer design for this transcript
 

Primer3Plus can design qPCR Primers that straddle exon-exon-junctions, which amplify only cDNA, not genomic DNA.
Click here to load the transcript sequence and exon structure into Primer3Plus

Exonprimer can design one pair of Sanger sequencing primers around every exon, located in non-genic sequence.
Click here to open Exonprimer with this transcript

To design primers for a non-coding sequence, zoom to a region of interest and select from the drop-down menu: View > In External Tools > Primer3


-  Genetic Association Studies of Complex Diseases and Disorders
  Genetic Association Database (archive): HECW1
CDC HuGE Published Literature: HECW1
Positive Disease Associations: Alcoholism , Blood Pressure , Lupus Erythematosus, Systemic
Related Studies:
  1. Alcoholism
    , , . [PubMed 0]
  2. Alcoholism
    , , . [PubMed 0]
  3. Blood Pressure
    Daniel Levy et al. BMC medical genetics 2007, Framingham Heart Study 100K Project: genome-wide associations for blood pressure and arterial stiffness., BMC medical genetics. [PubMed 17903302]
    These results of genome-wide association testing for blood pressure and arterial stiffness phenotypes in an unselected community-based sample of adults may aid in the identification of the genetic basis of hypertension and arterial disease, help identify high risk individuals, and guide novel therapies for hypertension. Additional studies are needed to replicate any associations identified in these analyses.
           more ... click here to view the complete list

-  Comparative Toxicogenomics Database (CTD)
  The following chemicals interact with this gene

+  Common Gene Haplotype Alleles
  Press "+" in the title bar above to open this section.

-  RNA-Seq Expression Data from GTEx (53 Tissues, 570 Donors)
  Highest median expression: 4.09 RPKM in Brain - Frontal Cortex (BA9)
Total median expression: 22.22 RPKM



View in GTEx track of Genome Browser    View at GTEx portal     View GTEx Body Map

+  Microarray Expression Data
  Press "+" in the title bar above to open this section.

-  mRNA Secondary Structure of 3' and 5' UTRs
 
RegionFold EnergyBasesEnergy/Base
Display As
5' UTR -241.60605-0.399 Picture PostScript Text
3' UTR -356.851413-0.253 Picture PostScript Text

The RNAfold program from the Vienna RNA Package is used to perform the secondary structure predictions and folding calculations. The estimated folding energy is in kcal/mol. The more negative the energy, the more secondary structure the RNA is likely to have.

-  Protein Domain and Structure Information
  InterPro Domains: Graphical view of domain structure
IPR000008 - C2_Ca-dep
IPR008973 - C2_Ca/lipid-bd_dom_CaLB
IPR018029 - C2_membr_targeting
IPR000569 - HECT
IPR001202 - WW_Rsp5_WWP

Pfam Domains:
PF00168 - C2 domain
PF00397 - WW domain
PF00632 - HECT-domain (ubiquitin-transferase)
PF16562 - N-terminal domain of E3 ubiquitin-protein ligase HECW1 and 2

SCOP Domains:
49562 - C2 domain (Calcium/lipid-binding domain, CaLB)
51045 - WW domain
56204 - Hect, E3 ligase catalytic domain

Protein Data Bank (PDB) 3-D Structure
MuPIT help
3L4H - X-ray MuPIT


ModBase Predicted Comparative 3D Structure on Q76N89
FrontTopSide
The pictures above may be empty if there is no ModBase structure for the protein. The ModBase structure frequently covers just a fragment of the protein. You may be asked to log onto ModBase the first time you click on the pictures. It is simplest after logging in to just click on the picture again to get to the specific info on that model.

-  Orthologous Genes in Other Species
  Orthologies between human, mouse, and rat are computed by taking the best BLASTP hit, and filtering out non-syntenic hits. For more distant species reciprocal-best BLASTP hits are used. Note that the absence of an ortholog in the table below may reflect incomplete annotations in the other species rather than a true absence of the orthologous gene.
MouseRatZebrafishD. melanogasterC. elegansS. cerevisiae
No orthologNo orthologGenome BrowserNo orthologNo orthologNo ortholog
Gene Details     
Gene Sorter     
  Ensembl   
  Protein Sequence   
  Alignment   

-  Gene Ontology (GO) Annotations with Structured Vocabulary
  Molecular Function:
GO:0004842 ubiquitin-protein transferase activity
GO:0016740 transferase activity
GO:0061630 ubiquitin protein ligase activity

Biological Process:
GO:0016567 protein ubiquitination
GO:0043161 proteasome-mediated ubiquitin-dependent protein catabolic process
GO:0090090 negative regulation of canonical Wnt signaling pathway

Cellular Component:
GO:0005737 cytoplasm
GO:0005829 cytosol


-  Descriptions from all associated GenBank mRNAs
  AB002320 - Homo sapiens KIAA0322 mRNA.
BC151227 - Homo sapiens HECT, C2 and WW domain containing E3 ubiquitin protein ligase 1, mRNA (cDNA clone MGC:166866 IMAGE:9007236), complete cds.
AK294918 - Homo sapiens cDNA FLJ58788 complete cds, highly similar to Homo sapiens HECT, C2 and WW domain containing E3 ubiquitin protein ligase 1 (HECW1), mRNA.
AK090799 - Homo sapiens cDNA FLJ33480 fis, clone BRAMY2002799, highly similar to Homo sapiens HECT, C2 and WW domain containing E3 ubiquitin protein ligase 1 (HECW1), mRNA.
AX746621 - Sequence 146 from Patent EP1308459.
AB384459 - Synthetic construct DNA, clone: pF1KA0322, Homo sapiens HECW1 gene for E3 ubiquitin-protein ligase HECW1, complete cds, without stop codon, in Flexi system.
AB048365 - Homo sapiens NEDL1 mRNA for NEDD4-like ubiquitin ligase 1, complete cds.
JD454550 - Sequence 435574 from Patent EP1572962.
JD460323 - Sequence 441347 from Patent EP1572962.
AK022679 - Homo sapiens cDNA FLJ12617 fis, clone NT2RM4001662.
CQ873787 - Sequence 206 from Patent WO2004076622.
DD413624 - Regulation of Mammalian Cells.
JD091743 - Sequence 72767 from Patent EP1572962.
JD302275 - Sequence 283299 from Patent EP1572962.
JD213760 - Sequence 194784 from Patent EP1572962.
JD250487 - Sequence 231511 from Patent EP1572962.
JD305618 - Sequence 286642 from Patent EP1572962.
JD511107 - Sequence 492131 from Patent EP1572962.
JD299054 - Sequence 280078 from Patent EP1572962.
JD418355 - Sequence 399379 from Patent EP1572962.
JD162325 - Sequence 143349 from Patent EP1572962.
JD377753 - Sequence 358777 from Patent EP1572962.
JD077475 - Sequence 58499 from Patent EP1572962.
JD207096 - Sequence 188120 from Patent EP1572962.
JD048929 - Sequence 29953 from Patent EP1572962.
JD353962 - Sequence 334986 from Patent EP1572962.
JD557781 - Sequence 538805 from Patent EP1572962.
JD521935 - Sequence 502959 from Patent EP1572962.
JD114851 - Sequence 95875 from Patent EP1572962.
JD206700 - Sequence 187724 from Patent EP1572962.
JD362146 - Sequence 343170 from Patent EP1572962.
JD045428 - Sequence 26452 from Patent EP1572962.
JD295780 - Sequence 276804 from Patent EP1572962.
JD524313 - Sequence 505337 from Patent EP1572962.

-  Biochemical and Signaling Pathways
  Reactome (by CSHL, EBI, and GO)

Protein Q76N89 (Reactome details) participates in the following event(s):

R-HSA-4641155 DVL1 is bound by the HECT ubiquitin ligase HECW1
R-HSA-4641159 DVL1 is ubiquitinated by HECW1
R-HSA-4641258 Degradation of DVL
R-HSA-201681 TCF dependent signaling in response to WNT
R-HSA-195721 Signaling by WNT
R-HSA-162582 Signal Transduction

-  Other Names for This Gene
  Alternate Gene Symbols: A7E2X0, A8MYS3, HECW1_HUMAN, KIAA0322, NEDL1, NM_015052, NP_055867, O15036, Q76N89, Q9HCC7
UCSC ID: uc003tid.1
RefSeq Accession: NM_015052
Protein: Q76N89 (aka HECW1_HUMAN)
CCDS: CCDS5469.2, CCDS69286.1

-  Gene Model Information
 
category: coding nonsense-mediated-decay: no RNA accession: NM_015052.3
exon count: 30CDS single in 3' UTR: no RNA size: 6839
ORF size: 4821CDS single in intron: no Alignment % ID: 99.99
txCdsPredict score: 9517.00frame shift in genome: no % Coverage: 100.00
has start codon: yes stop codon in genome: no # of Alignments: 1
has end codon: yes retained intron: no # AT/AC introns 0
selenocysteine: no end bleed into intron: 0# strange splices: 0
Click here for a detailed description of the fields of the table above.

-  Methods, Credits, and Use Restrictions
  Click here for details on how this gene model was made and data restrictions if any.